Port-A-Cath: A Real-Life Study in Patients Receiving Chemotherapy
Keywords:
Port-A-Cath; Peripheral Venous Access; Chemotherapy; Safety; Quality of LifeAbstract
Background: Chemotherapy delivered via Peripheral Venous Access (PVA) is associated with significant complications, including pain, swelling, and phlebitis. The Port-A-Cath (PAC) offers improved venous access and patient mobility during treatment.
Objective: This study aimed to assess the efficacy, safety, and quality-of-life impact of PAC in chemotherapy patients, comparing it with the traditional PVA method.
Methods: A single-centre, prospective cohort study was conducted at Bangladesh Specialized Hospital between 2019 and 2023, including 54 patients previously treated with PVA who subsequently transitioned to PAC. Pain and anxiety were assessed using the Visual Analogue Scale (VAS) and the Modified Facial Anxiety Scale (M-FAS), respectively. Patient satisfaction was assessed using a structured 5-point Likert-scale questionnaire administered at the end of the chemotherapy regimen. Paired t-tests were used to compare outcomes between PVA and PAC, with p < 0.05 considered statistically significant. Results: The mean age of participants was 49.7 years (SD 13.9) (M:F ratio = 1:1.7). During PVA use, patients underwent an average of 4.23 chemotherapy cycles (SD = 5.31) with a mean pain score of 4.0 (SD = 1.25); 64% reported moderate anxiety (M-FAS ≥ 4), and complications (chiefly phlebitis and extravasation) occurred in 64% of cases. After transition to PAC, the average number of cycles increased to 12 (SD = 7.85), the mean pain score fell to 1.4 (SD = 0.9), 80% of patients reported mild or no anxiety, and only 9.3% (5/54) experienced complications, mainly catheter-related infection. Statistically significant improvements were observed for pain (p = 0.002), anxiety (p = 0.004), and mobility restriction (p = 0.001). Unrestricted mobility was reported by 100% of patients with PAC compared with 50% during PVA use, and 92.6% of patients reported satisfaction with PAC.
Conclusion: Compared with PVA, PAC was associated with superior safety, efficacy, and patient comfort, with significant reductions in pain, anxiety, and mobility restriction during chemotherapy.
J Bangladesh Coll Phys Surg 2026; 44: 160-168
13
10
Downloads
Published
How to Cite
Issue
Section
License
Submission of a manuscript for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted manuscripts become the permanent property of the Journal of Bangladesh College of Physicians and Surgeons and may not be reproduced by any means in whole or in part without the written consent of the publisher.
No part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Reprints of any article in the Journal will be available from the publisher.
